Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.

about

Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.

Item

http://www.wikidata.org/entity/Q47594827

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@en

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@nl

type

Item

label

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@en

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@nl

prefLabel

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@en

Tethered-variable CL bispecifi ...... bispecific antibody screening.

@nl

P1476

Tethered-variable CL bispecifi ...... bispecific antibody screening

@en

P2093

Angie Yee

http://www.w3.org/2001/XMLSchema#string

Diana Ronai Dunshee

http://www.w3.org/2001/XMLSchema#string

Farzam Farahi

http://www.w3.org/2001/XMLSchema#string

Hok Seon Kim

http://www.w3.org/2001/XMLSchema#string

Ingrid Kim

http://www.w3.org/2001/XMLSchema#string

James A Ernst

http://www.w3.org/2001/XMLSchema#string

Jo-Anne Hongo

http://www.w3.org/2001/XMLSchema#string

Junichiro Sonoda

http://www.w3.org/2001/XMLSchema#string

Raymond K Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair

Improving biophysical properties of a bispecific antibody scaffold to aid developability

Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface

Alternative molecular formats and therapeutic applications for bispecific antibodies

Are BiTEs the "missing link" in cancer therapy?

Cancer immunotherapy comes of age

A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.

Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG.

Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries.

P304

627-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/PROTEIN/GZX034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Spiess

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28985411

http://www.w3.org/2001/XMLSchema#string

P932

5914367

http://www.w3.org/2001/XMLSchema#string